Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1997 Dec;226(6):714–724. doi: 10.1097/00000658-199712000-00008

First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up.

E Ancona 1, A Ruol 1, C Castoro 1, V Chiarion-Sileni 1, S Merigliano 1, S Santi 1, L Bonavina 1, A Peracchia 1
PMCID: PMC1191144  PMID: 9409570

Abstract

OBJECTIVE: The objective of this prospective, nonrandomized study was to evaluate the immediate and long-term results of first-line chemotherapy and possible surgery in locally advanced, presumably T4 squamous cell esophageal cancer. SUMMARY BACKGROUND DATA: Locally advanced esophageal cancer is rarely operable and has a dismal prognosis. For this reason, neoadjuvant cytoreductive treatments are more and more frequently used with the aim of downstaging the tumor, increasing the resection rate, and possibly improving survival. Methods: From January 1983 to December 1991, 163 consecutive patients with a presumedly T4 squamous cell carcinoma of the thoracic esophagus (group A) received on average 2.5 cycles (range, 1-6) of first-line chemotherapy with cisplatin (100 mg/m2 on day 1) and 5-fluorouracil (1000 mg/m2 per day, in continuous infusion from day 1 through day 5). Chemotherapy was followed by surgery when adequate downstaging of the tumor was obtained. RESULTS: Chemotherapy toxicity was WHO grade 0 to 2 in 80% of cases, but 3 toxic deaths (1.9%) occurred. Restaging suggested a downstaging of the tumor in 101 of 163 patients (62%), but only 85 patients (52%) underwent resection surgery; it was complete or R0 in 52 (32%) and incomplete or R1-2 in 33. Overall postoperative mortality was 11.7% (10 of 85), morbidity 41% (35 of 85). Complete pathologic response was documented in 6 patients, and significant downstaging to pStage I, IIA, or IIB occurred in 25 more patients. The overall 5-year survival was 11 % (median, 11 months). After resection surgery, the 5-year survival was 20% (median, 16 months); none of the nonresponders survived 4 years after palliative treatments without resection (median survival, 5 months). The 5-year survival rate of the 52 patients undergoing an R0 resection was 29% (median, 23 months). Stratifying patients according to the R, pT, pN, and pStage classifications, the survival curves were comparable to the corresponding data obtained in the 587 group B patients with "potentially resectable" esophageal cancer who underwent surgery alone during the same period. Furthermore, the results were improved in comparison with 136 previous or subsequent patients with a locally advanced tumor who did not undergo neoadjuvant treatments (group C). In these patients, the R0 resection rate was 7%, and the overall 5-year survival was 3% (median, 5 months). CONCLUSION: Although nonrandomized, these results suggest that in locally advanced esophageal carcinoma, first-line chemotherapy increases the resection rate and improves the overall long-term survival. In responding patients who undergo R0 resection surgery, the prognosis depends on the final pathologic stage and not on the initial pretreatment stage.

Full text

PDF
720

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ajani J. A., Roth J. A., Ryan B., McMurtrey M., Rich T. A., Jackson D. E., Abbruzzese J. L., Levin B., DeCaro L., Mountain C. Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol. 1990 Jul;8(7):1231–1238. doi: 10.1200/JCO.1990.8.7.1231. [DOI] [PubMed] [Google Scholar]
  2. Ajani J. A., Ryan B., Rich T. A., McMurtrey M., Roth J. A., DeCaro L., Levin B., Mountain C. Prolonged chemotherapy for localised squamous carcinoma of the oesophagus. Eur J Cancer. 1992;28A(4-5):880–884. doi: 10.1016/0959-8049(92)90140-w. [DOI] [PubMed] [Google Scholar]
  3. Carey R. W., Hilgenberg A. D., Wilkins E. W., Choi N. C., Mathisen D. J., Grillo H. Preoperative chemotherapy followed by surgery with possible postoperative radiotherapy in squamous cell carcinoma of the esophagus: evaluation of the chemotherapy component. J Clin Oncol. 1986 May;4(5):697–701. doi: 10.1200/JCO.1986.4.5.697. [DOI] [PubMed] [Google Scholar]
  4. Chan K. W., Chan E. Y., Chan C. W. Carcinoma of the esophagus. An autopsy study of 231 cases. Pathology. 1986 Oct;18(4):400–405. doi: 10.3109/00313028609087559. [DOI] [PubMed] [Google Scholar]
  5. De Besi P., Sileni V. C., Salvagno L., Tremolada C., Cartei G., Fosser V., Paccagnella A., Peracchia A., Fiorentino M. Phase II study of cisplatin, 5-FU, and allopurinol in advanced esophageal cancer. Cancer Treat Rep. 1986 Jul;70(7):909–910. [PubMed] [Google Scholar]
  6. Earlam R., Cunha-Melo J. R. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg. 1980 Jun;67(6):381–390. doi: 10.1002/bjs.1800670602. [DOI] [PubMed] [Google Scholar]
  7. Forastiere A. A., Orringer M. B., Perez-Tamayo C., Urba S. G., Husted S., Takasugi B. J., Zahurak M. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol. 1990 Jan;8(1):119–127. doi: 10.1200/JCO.1990.8.1.119. [DOI] [PubMed] [Google Scholar]
  8. Giuli R., Gignoux M. Treatment of carcinoma of the esophagus. Retrospective study of 2,400 patients. Ann Surg. 1980 Jul;192(1):44–52. doi: 10.1097/00000658-198007000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hilgenberg A. D., Carey R. W., Wilkins E. W., Jr, Choi N. C., Mathisen D. J., Grillo H. C. Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg. 1988 Apr;45(4):357–363. doi: 10.1016/s0003-4975(98)90004-2. [DOI] [PubMed] [Google Scholar]
  10. Iizuka T., Kakegawa T., Ide H., Ando N., Watanabe H., Tanaka O., Takagi I., Isono K., Ishida K., Arimori M. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial. Jpn J Clin Oncol. 1992 Jun;22(3):172–176. [PubMed] [Google Scholar]
  11. Ilson D. H., Kelsen D. P. Combined modality therapy in the treatment of esophageal cancer. Semin Oncol. 1994 Aug;21(4):493–507. [PubMed] [Google Scholar]
  12. Katlic M. R., Wilkins E. W., Jr, Grillo H. C. Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg. 1990 May;99(5):929–938. [PubMed] [Google Scholar]
  13. Kelsen D. P., Ilson D. H. Chemotherapy and combined-modality therapy for esophageal cancer. Chest. 1995 Jun;107(6 Suppl):224S–232S. doi: 10.1378/chest.107.6_supplement.224s. [DOI] [PubMed] [Google Scholar]
  14. Kies M. S., Rosen S. T., Tsang T. K., Shetty R., Schneider P. A., Wallemark C. B., Shields T. W. Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer. Cancer. 1987 Nov 1;60(9):2156–2160. doi: 10.1002/1097-0142(19871101)60:9<2156::aid-cncr2820600906>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  15. Kok T. C., Tilanus H. W. Neoadjuvant treatment in oesophageal cancer: the needs for future trials. The Rotterdam Esophageal Tumor Study Group. Eur J Surg Oncol. 1996 Aug;22(4):323–325. doi: 10.1016/s0748-7983(96)90066-9. [DOI] [PubMed] [Google Scholar]
  16. LORTAT-JACOB J. L. Résultats du traitement chirurgical du cancer de l'oesophage. Mem Acad Chir (Paris) 1957 Mar 20;83(10-11):348–355. [PubMed] [Google Scholar]
  17. Leichman L., Berry B. T. Experience with cisplatin in treatment regimens for esophageal cancer. Semin Oncol. 1991 Feb;18(1 Suppl 3):64–72. [PubMed] [Google Scholar]
  18. Leichman L., Steiger Z., Seydel H. G., Vaitkevicius V. K. Combined preoperative chemotherapy and radiation therapy for cancer of the esophagus: the Wayne State University, Southwest Oncology group and Radiation Therapy Oncology Group experience. Semin Oncol. 1984 Jun;11(2):178–185. [PubMed] [Google Scholar]
  19. Miller A. B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 1981 Jan 1;47(1):207–214. doi: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  20. Müller J. M., Erasmi H., Stelzner M., Zieren U., Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg. 1990 Aug;77(8):845–857. doi: 10.1002/bjs.1800770804. [DOI] [PubMed] [Google Scholar]
  21. Nygaard K., Hagen S., Hansen H. S., Hatlevoll R., Hultborn R., Jakobsen A., Mäntyla M., Modig H., Munck-Wikland E., Rosengren B. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg. 1992 Nov-Dec;16(6):1104–1110. doi: 10.1007/BF02067069. [DOI] [PubMed] [Google Scholar]
  22. Orringer M. B., Forastiere A. A., Perez-Tamayo C., Urba S., Takasugi B. J., Bromberg J. Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma. Ann Thorac Surg. 1990 Mar;49(3):348–355. doi: 10.1016/0003-4975(90)90237-z. [DOI] [PubMed] [Google Scholar]
  23. Picus D., Balfe D. M., Koehler R. E., Roper C. L., Owen J. W. Computed tomography in the staging of esophageal carcinoma. Radiology. 1983 Feb;146(2):433–438. doi: 10.1148/radiology.146.2.6849089. [DOI] [PubMed] [Google Scholar]
  24. Roth J. A., Pass H. I., Flanagan M. M., Graeber G. M., Rosenberg J. C., Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg. 1988 Aug;96(2):242–248. [PubMed] [Google Scholar]
  25. Schlag P. M. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. Arch Surg. 1992 Dec;127(12):1446–1450. doi: 10.1001/archsurg.1992.01420120080015. [DOI] [PubMed] [Google Scholar]
  26. Shields T. W., Rosen S. T., Hellerstein S. M., Tsang T., Ujiki G. T., Kies M. S. Multimodality approach to treatment of carcinoma of the esophagus. Arch Surg. 1984 May;119(5):558–562. doi: 10.1001/archsurg.1984.01390170054011. [DOI] [PubMed] [Google Scholar]
  27. Sons H. U., Borchard F. Esophageal cancer. Autopsy findings in 171 cases. Arch Pathol Lab Med. 1984 Dec;108(12):983–988. [PubMed] [Google Scholar]
  28. Stahl M., Wilke H., Fink U., Stuschke M., Walz M. K., Siewert J. R., Molls M., Fett W., Makoski H. B., Breuer N. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol. 1996 Mar;14(3):829–837. doi: 10.1200/JCO.1996.14.3.829. [DOI] [PubMed] [Google Scholar]
  29. Stahl M., Wilke H., Meyer H. J., Preusser P., Berns T., Fink U., Achterrath W., Knipp H., Harstrick A., Berger M. 5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus. Eur J Cancer. 1994;30A(3):325–328. doi: 10.1016/0959-8049(94)90250-x. [DOI] [PubMed] [Google Scholar]
  30. Vogel S. B., Mendenhall W. M., Sombeck M. D., Marsh R., Woodward E. R. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg. 1995 Jun;221(6):685–695. doi: 10.1097/00000658-199506000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wang L. S., Chi K. H., Hu M. H., Fahn H. J., Huang M. H. Management for patients with advanced T4 epidermoid carcinoma of the esophagus. J Surg Oncol. 1996 May;62(1):22–29. doi: 10.1002/(SICI)1096-9098(199605)62:1<22::AID-JSO5>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  32. Wang P., Chien K. Surgical treatment of carcinoma of the esophagus and cardia among the Chinese. Ann Thorac Surg. 1983 Feb;35(2):143–151. doi: 10.1016/s0003-4975(10)61450-6. [DOI] [PubMed] [Google Scholar]
  33. al-Sarraf M. The current status of combined modality treatment containing chemotherapy in patients with esophageal cancer. Int J Radiat Oncol Biol Phys. 1990 Sep;19(3):813–815. doi: 10.1016/0360-3016(90)90519-p. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES